Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human MAP3K12 binding inhibitory protein 1 aa 300 to the C-terminus (Cysteine residue). The exact sequence is proprietary.
Database link: Q9NS73
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab181040 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/5000. Predicted molecular weight: 39 kDa.|
|ICC/IF||1/100 - 1/250.|
|IP||1/10 - 1/100.|
Immunofluorescent staining of HepG2 cells labeling MAP3K12 binding inhibitory protein 1 with ab181040 at 1/100 dilution.
Western blot analysis on immunoprecipitation pellet from (Lane 1) 293T cell lysate or (Lane 2) 1XPBS (negative control) using ab181040 at 1/10 dilution for IP, and HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG.
ab181040 has not yet been referenced specifically in any publications.